Our present study provides the supportive and underlying information for this therapeutic effect and implies that the inverse diurnal patterns of TRPV1 and/or NGF gene expression might contribute to the hypersensitivity in the evening or at night in patients with severe GERD. This evidence concerns the gene TRPV1 and gastroesophageal reflux disease.